<p>Muscular dystrophies (MDs) are a set of neuromuscular diseases characterized by progressive muscle weakness and wasting. Their pathophysiology entails several aberrant genetic pathways including the perturbation of microRNA (miRNA) and other non-coding RNA (ncRNA) levels and functions, and the subsequent dysregulation of their downstream targets. In healthy tissue, ncRNAs exert their influence by fine-tuning physiological mechanisms. However, in dystrophic conditions, these ncRNAs become involved in modulation of pathological mechanisms. The main pathomechanism themes that involve ncRNAs and proteins in MD are myogenesis insufficiency, structural instability, destructive pathways, and signaling failure. This review attempts to delineate all the major contributory ncRNAs, particularly miRNAs, as well as their associated proteins involved in disease initiation, maintenance, and outcomes across the spectrum of MD subtypes.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies

  • Farah Gamal Abdelrehim,
  • Zade Sadek,
  • Salma A. Fahim,
  • Nada El-Ekiaby,
  • Ahmed Ihab Abdelaziz,
  • Injie Omar Fawzy

摘要

Muscular dystrophies (MDs) are a set of neuromuscular diseases characterized by progressive muscle weakness and wasting. Their pathophysiology entails several aberrant genetic pathways including the perturbation of microRNA (miRNA) and other non-coding RNA (ncRNA) levels and functions, and the subsequent dysregulation of their downstream targets. In healthy tissue, ncRNAs exert their influence by fine-tuning physiological mechanisms. However, in dystrophic conditions, these ncRNAs become involved in modulation of pathological mechanisms. The main pathomechanism themes that involve ncRNAs and proteins in MD are myogenesis insufficiency, structural instability, destructive pathways, and signaling failure. This review attempts to delineate all the major contributory ncRNAs, particularly miRNAs, as well as their associated proteins involved in disease initiation, maintenance, and outcomes across the spectrum of MD subtypes.